ReviewCancers2022

PI3K Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Current Status and Future Perspectives.

Iwona Hus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.